ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,308.13
      0.09%
      US Tech 100
      18,174.40
      0.58%
      Dow Jones
      39,806.77
      -0.49%
      Brent Oil
      83.495
      -0.12%
      Bitcoin
      69,588.36
      5.00%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adaptive Biotechnologies Corporation (ADPT)

      7. Adaptive Biotechnologies Corporation (ADPT) News

      ADPT

      Adaptive Biotechnologies (ADPT)

      Adaptive Biotechnologies Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADPT
      DateTimeSourceHeadlineSymbolCompany
      05/17/20246:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      05/07/20244:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADPTAdaptive Biotechnologies Corporation
      05/07/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADPTAdaptive Biotechnologies Corporation
      05/07/20244:05PMGlobeNewswire Inc.Adaptive Biotechnologies Reports First Quarter 2024 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
      04/17/20244:05PMGlobeNewswire Inc.Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
      04/02/20244:05PMGlobeNewswire Inc.Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 RevenueNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/27/20248:30AMGlobeNewswire Inc.Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      03/06/20247:38PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      02/22/20244:05PMGlobeNewswire Inc.Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
      02/14/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADPTAdaptive Biotechnologies Corporation
      02/14/20244:05PMGlobeNewswire Inc.Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ADPTAdaptive Biotechnologies Corporation
      01/29/20244:05PMGlobeNewswire Inc.Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024NASDAQ:ADPTAdaptive Biotechnologies Corporation
      01/29/20244:00PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADPTAdaptive Biotechnologies Corporation
      12/27/20234:05PMGlobeNewswire Inc.Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ADPTAdaptive Biotechnologies Corporation
      12/09/20238:30AMGlobeNewswire Inc.Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual MeetingNASDAQ:ADPTAdaptive Biotechnologies Corporation
      12/05/20237:30AMGlobeNewswire Inc.Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual MeetingNASDAQ:ADPTAdaptive Biotechnologies Corporation
      11/20/20235:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADPTAdaptive Biotechnologies Corporation
      11/09/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADPTAdaptive Biotechnologies Corporation
      11/09/20234:05PMGlobeNewswire Inc.Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADPTAdaptive Biotechnologies Corporation
      11/07/20237:30AMGlobeNewswire Inc.Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy PipelineNASDAQ:ADPTAdaptive Biotechnologies Corporation
       Showing the most relevant articles for your search:NASDAQ:ADPT